isosorbide-5-mononitrate has been researched along with Cardiovascular Stroke in 49 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (26.53) | 18.7374 |
| 1990's | 22 (44.90) | 18.2507 |
| 2000's | 11 (22.45) | 29.6817 |
| 2010's | 2 (4.08) | 24.3611 |
| 2020's | 1 (2.04) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Jiang, Z; Li, Y; Peng, Y; Shi, S; Song, J | 1 |
| Mironova, TF; Safronova, ÉA; Shadrina, IM | 1 |
| Lau, CP; Pong, V; Siu, CW; Tse, HF; Yiu, KH | 1 |
| Eskilsson, J; Ohlin, H; Roijer, A; Thilen, U; Tingberg, E | 1 |
| Bianchi, F; Cremonesi, G; Geraci, E; Gramenzi, S; Hernandez-Bernal, F; Labarta, V; Latini, R; Maggioni, AP; Marino, P; Nicolosi, GL; Sarcina, G; Staszewsky, L; Tognoni, G | 1 |
| Celibała, R; Maciejewicz, J; Maziarz, A; Wiśniewska, M; Wiśniewski, M | 1 |
| Bai, A; Calvillo, L; De Angelis, N; Fiordaliso, F; Ghezzi, P; Latini, R; Masson, S; Pollicino, L; Salio, M; Santangelo, F | 1 |
| Kloner, RA | 1 |
| Martsevich, SIu | 1 |
| Gottsäter, A; Ohlin, AK; Ohlin, H; Tingberg, E | 1 |
| Ohlin, H; Roijer, A; Thilen, U; Tingberg, E | 1 |
| Häcker, W; Müller, G; Schneider, B | 1 |
| Schmidt, G | 1 |
| Bussmann, WD; Kaltenbach, M; Reifart, N; Schirmer, M | 1 |
| Kurosaki, M; Lagrasta, C; Latini, R; Olivetti, G; Porzio, S; Riva, E | 1 |
| Brandt, D; Dorda, W; Pichler, M; Teubl, H | 1 |
| Blinston, GE; Jugdutt, BI; Jugdutt, SJ; Khan, MI | 1 |
| Held, P; Hornestam, B; Jonsson, UE; McClennen, W | 1 |
| Cowan, JC; Morris, JL; Smyllie, JH; Zaman, AG | 1 |
| Ahlner, J; Torfgård, KE | 1 |
| Fehske, W; Honikel, HJ | 1 |
| Budaj, A; Cedro, K; Collins, R; Fitzgerald, L; Flather, M; Hargreaves, A; Jacob, A; Kolettis, T; Millane, T; Pipilis, A | 1 |
| Rezende, M | 1 |
| Appleby, P; Coats, A; Collins, R; Conway, M; Flather, M; Pipilis, A; Sleight, P | 1 |
| Allenova, IB; El'kina, NS; Golikov, AP | 1 |
| Dłuzniewski, M; Janas, J; Jurgiel, R; Król, J; Kuch, J; Lada, W; Mamcarz, A; Pawińska, M; Podogrodzka, B; Raczkowska, A; Sitkiewicz, W; Swiatowiec, A | 1 |
| Hayashi, T; Ishikawa, K; Kanamasa, K; Kimura, A; Kitayama, K; Miyataka, M; Takenaka, T; Yabushita, H; Yamamoto, T | 1 |
| Ikeda, N; Ino, T; Saito, M; Yamada, S; Yasu, T | 1 |
| Gendel'man, AM; Lazebnik, LB; Tereshchenko, SN | 1 |
| Gazarian, GA; Golikov, AP; Spasskiĭ, AA | 1 |
| Heidemann, HT; Meissner, A; Osterkamp, U; Petersenn, S; Schulte, HM; Simon, R | 1 |
| Bennett, ED; Fitzgerald, LJ | 1 |
| Feng, JZ; Feng, XH; Schneeweiss, A | 1 |
| Batinić, Z; Goldner, V; Pavicić, L; Rezaković, DE; Stalec, J; Weiss, M | 1 |
| Wrobel, N | 1 |
| Bushe, CJ | 1 |
| Akhras, F; Chambers, J; Jackson, G; Jefferies, S | 1 |
| De Magalhães, HM; Gun, C; Piegas, LS; Ramos, RF; Romano, ER; Sousa, JE; Timerman, A; Timerman, S | 1 |
| Daskalov, TR | 1 |
| Betriú, A; Cloquell, G; González Maqueda, I; López-Sendón, J; Martín Jadraque, L; Mont, J; Sanz, G | 1 |
| De Martini, M; Foresti, A; Lotto, A; Massari, FM; Valentini, R | 1 |
| Chouraqui, P; Katz, A; Neufeld, HN; Rabinowitz, B; Shotan, A | 1 |
| Daskalov, T | 1 |
| Adams, CB; Bevan, JS; Burke, CW; Oza, AM | 1 |
| Gammage, MD; Murray, RG | 1 |
| Gammage, MD; Littler, WA; Murray, RG | 1 |
3 review(s) available for isosorbide-5-mononitrate and Cardiovascular Stroke
| Article | Year |
|---|---|
Cardiovascular effects of the 3 phosphodiesterase-5 inhibitors approved for the treatment of erectile dysfunction.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Adrenergic alpha-Antagonists; Arteriosclerosis; Blood Pressure; Carbolines; Contraindications; Coronary Disease; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Drug Interactions; Endothelium, Vascular; Erectile Dysfunction; Heart Rate; Humans; Hypotension; Imidazoles; Isosorbide Dinitrate; Male; Molecular Structure; Myocardial Infarction; Nitric Oxide Donors; Nitroglycerin; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperazines; Purines; Randomized Controlled Trials as Topic; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride; Vasodilation; Vasodilator Agents | 2004 |
[Nitrates. The place in contemporary therapy of ischemic heart disease].
Topics: Angina Pectoris; Contraindications; Delayed-Action Preparations; Humans; Isosorbide Dinitrate; Myocardial Infarction; Myocardial Ischemia; Nitrates; Nitroglycerin; Time Factors; Vasodilator Agents | 2005 |
Mechanisms of action of nitrates.
Topics: Angina Pectoris; Blood Platelets; Cyclic GMP-Dependent Protein Kinases; Cytochrome P-450 Enzyme System; Esterases; Glutathione Transferase; Heart; Heart Failure; Humans; Isosorbide Dinitrate; Muscle Relaxation; Muscle, Smooth, Vascular; Myocardial Infarction; Nitrates; Nitroglycerin; Oxygen Consumption; Structure-Activity Relationship; Vasodilator Agents | 1994 |
18 trial(s) available for isosorbide-5-mononitrate and Cardiovascular Stroke
| Article | Year |
|---|---|
[Autonomous pharmacodynamics of organic nitrates in patients with unstable angina].
Topics: Angina, Unstable; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Nitroglycerin; Treatment Outcome; Vasodilator Agents | 2013 |
Randomized, double-blind, placebo-controlled long-term study of isosorbide-5-mononitrate therapy in patients with left ventricular dysfunction after acute myocardial infarction.
Topics: Aged; Atrial Natriuretic Factor; Delayed-Action Preparations; Diuretics; Double-Blind Method; Drug Therapy, Combination; Echocardiography; Female; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Peptide Fragments; Ramipril; Ventricular Dysfunction, Left | 2003 |
Beneficial effects of angiotensin-converting enzyme inhibitor and nitrate association on left ventricular remodeling in patients with large acute myocardial infarction: the Delapril Remodeling after Acute Myocardial Infarction (DRAMI) trial.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Female; Humans; Indans; Isosorbide Dinitrate; Lisinopril; Male; Middle Aged; Myocardial Infarction; Placebo Effect; Statistics as Topic; Vasodilator Agents; Ventricular Remodeling | 2003 |
[The impact of nitrates and mono-therapy and nitrates combined with angiotensin converting enzyme inhibitors on left ventricular remodeling and exercise capacity in patients after acute myocardial infarction].
Topics: Adult; Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Delayed-Action Preparations; Electrocardiography; Exercise Test; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Nitric Oxide Donors; Time Factors; Treatment Outcome; Vasodilator Agents; Ventricular Function, Left; Ventricular Remodeling | 2003 |
Lipid peroxidation is not increased in heart failure patients on modern pharmacological therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Captopril; Comorbidity; Delayed-Action Preparations; Dinoprost; Female; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Lipid Peroxidation; Losartan; Male; Malondialdehyde; Middle Aged; Myocardial Infarction; Natriuretic Peptide, Brain; Nitric Oxide Donors; Oxidative Stress; Ramipril; Stroke Volume; Ultrasonography; Ventricular Dysfunction, Left | 2006 |
Neurohumoral changes in patients with left ventricular dysfunction following acute myocardial infarction and the effect of nitrate therapy: a randomized, double-blind, placebo-controlled long-term study.
Topics: Adult; Aged; Aldosterone; Atrial Natriuretic Factor; Double-Blind Method; Echocardiography; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Natriuretic Peptide, Brain; Norepinephrine; Renin; Substance P; Ventricular Dysfunction, Left | 2006 |
Intra-individual comparison of the action of equal doses of isosorbide-5-endomononitrate, slow-release isosorbide dinitrate and placebo in patients with coronary heart disease.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Electrocardiography; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Nitroglycerin | 1983 |
[Isosorbide-5-mononitrate in silent ischemia].
Topics: Adult; Aged; Coronary Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Electrocardiography, Ambulatory; Exercise Test; Female; Heart Conduction System; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Vasodilator Agents | 1995 |
ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative
Topics: Administration, Oral; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Delayed-Action Preparations; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Isosorbide Dinitrate; Magnesium Sulfate; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Thrombolytic Therapy; Vasodilator Agents | 1995 |
Nitrates in myocardial infarction: influence on infarct size, reperfusion, and ventricular remodelling.
Topics: Aged; Delayed-Action Preparations; Double-Blind Method; Echocardiography; Humans; Infusions, Intravenous; Isosorbide Dinitrate; Middle Aged; Myocardial Infarction; Vasodilator Agents; Ventricular Function, Left | 1995 |
[Hemodynamics effects of continuous infusion of molsidomine and nitrates and subsequent oral medication in therapy of acute myocardial infarct].
Topics: Administration, Oral; Aged; Aged, 80 and over; Female; Hemodynamics; Humans; Infusions, Intravenous; Isosorbide Dinitrate; Male; Middle Aged; Molsidomine; Myocardial Infarction; Nitrates; Nitroglycerin; Vasodilator Agents | 1994 |
Randomized controlled trial of oral captopril, of oral isosorbide mononitrate and of intravenous magnesium sulphate started early in acute myocardial infarction: safety and haemodynamic effects. ISIS-4 (Fourth International Study of Infarct Survival) Pilo
Topics: Captopril; Drug Administration Schedule; Drug Therapy, Combination; Female; Hemodynamics; Humans; Isosorbide Dinitrate; Magnesium Sulfate; Male; Middle Aged; Myocardial Infarction; Patient Compliance; Pilot Projects; Research Design; Safety; Time Factors; Vasodilator Agents | 1994 |
Hemodynamic effects of captopril and isosorbide mononitrate started early in acute myocardial infarction: a randomized placebo-controlled study.
Topics: Aged; Captopril; Double-Blind Method; Drug Therapy, Combination; Female; Hemodynamics; Humans; Isosorbide; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Pilot Projects | 1993 |
The effects of oral isosorbide 5-mononitrate on mortality following acute myocardial infarction: a multicentre study.
Topics: Analysis of Variance; Double-Blind Method; Female; Humans; Isosorbide Dinitrate; Male; Multicenter Studies as Topic; Myocardial Infarction; Placebos; Randomized Controlled Trials as Topic | 1990 |
Efficacy of isosorbide-5-mononitrate on painful and silent myocardial ischemia after myocardial infarction.
Topics: Adult; Aged; Angina Pectoris; Drug Administration Schedule; Electrocardiography, Ambulatory; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Randomized Controlled Trials as Topic; Single-Blind Method | 1990 |
Intravenous isosorbide-5-mononitrate in the treatment of acute myocardial infarction.
Topics: Clinical Trials as Topic; Female; Hemodynamics; Humans; Infusions, Intravenous; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Time Factors | 1990 |
A randomised double-blind crossover study of isosorbide mononitrate and nifedipine retard in chronic stable angina.
Topics: Aged; Angina Pectoris; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Exercise Test; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Nifedipine; Nitroglycerin; Random Allocation; Vasodilator Agents | 1989 |
Controlled study of the haemodynamic effects of isosorbide 5-mononitrate in acute myocardial infarction.
Topics: Acute Disease; Administration, Oral; Aged; Female; Hemodynamics; Humans; Infusions, Intravenous; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Nitroglycerin | 1987 |
28 other study(ies) available for isosorbide-5-mononitrate and Cardiovascular Stroke
| Article | Year |
|---|---|
High-dose nitrate therapy recovers the expression of subtypes α
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Disease Models, Animal; Drug Therapy, Combination; Heart Failure; Imidazoles; Isosorbide Dinitrate; Kidney Cortex; Male; Myocardial Infarction; Rats, Wistar; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, beta; Receptors, Angiotensin; Renin-Angiotensin System; Tetrazoles; Time Factors | 2020 |
Long-term oral nitrate therapy is associated with adverse outcome in diabetic patients following elective percutaneous coronary intervention.
Topics: Administration, Oral; Aged; Angioplasty, Balloon, Coronary; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2; Drug Administration Schedule; Female; Hong Kong; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Vasodilator Agents | 2011 |
In vivo cardioprotection by N-acetylcysteine and isosorbide 5-mononitrate in a rat model of ischemia-reperfusion.
Topics: Acetylcysteine; Animals; Blood Pressure; Drug Therapy, Combination; Free Radical Scavengers; Isosorbide Dinitrate; Male; Monocytes; Myocardial Infarction; Myocardial Reperfusion Injury; Neutrophils; Nitric Oxide Donors; Rats; Rats, Sprague-Dawley | 2003 |
Nitroglycerin: a blast from the past remains a trusted standby. Nitrates offer quick, effective relief from a common heart disease symptom, often for just pennies per dose.
Topics: Angina Pectoris; Drug Interactions; Humans; Isosorbide Dinitrate; Myocardial Infarction; Nitroglycerin; Vasodilator Agents | 2005 |
[Comparative clinical evaluation of ISDN and 5-ISMN as exemplified by Mono Mack 20 mg/40 mg].
Topics: Animals; Coronary Disease; Dogs; Drug Evaluation; Half-Life; Hemodynamics; Humans; Isosorbide Dinitrate; Myocardial Infarction; Rats | 1983 |
[Hemodynamic effect, effect duration and pharmacokinetics of 80 mg of isosorbide-5-mononitrate in acute myocardial infarct].
Topics: Acute Disease; Adult; Aged; Hemodynamics; Humans; Isosorbide; Isosorbide Dinitrate; Middle Aged; Myocardial Infarction | 1981 |
Effects of an early treatment with lisinopril and isosorbide-5-mononitrate on hemodynamics and late ventricular remodelling in rats with 9-week myocardial infarction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Disease Models, Animal; Follow-Up Studies; Hemodynamics; Isosorbide Dinitrate; Lisinopril; Male; Myocardial Infarction; Organ Size; Rats; Vasodilator Agents; Ventricular Dysfunction, Left | 1995 |
Impact of left ventricular unloading after late reperfusion of canine anterior myocardial infarction on remodeling and function using isosorbide-5-mononitrate.
Topics: Animals; Arrhythmias, Cardiac; Collagen; Dogs; Echocardiography; Female; Heart Aneurysm; Hemodynamics; Isosorbide Dinitrate; Male; Myocardial Contraction; Myocardial Infarction; Myocardial Reperfusion; Myocardium; Time Factors; Vasodilator Agents; Ventricular Function, Left | 1995 |
The plasma concentrations of isosorbide 5-mononitrate (5-ISMN) administered in an extended-release form to patients with acute myocardial infarction.
Topics: Adult; Aged; Aged, 80 and over; Delayed-Action Preparations; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Vasodilator Agents | 1995 |
[The use of oral and intravenous isosorbide mononitrate (5-MNi) in the acute phase of myocardial infarction].
Topics: Administration, Oral; Aged; Aged, 80 and over; Female; Hemodynamics; Humans; Injections, Intravenous; Isosorbide Dinitrate; Male; Myocardial Infarction; Vasodilator Agents | 1993 |
[Antianginal effectiveness of regular isosorbide-5-mononitrate (monochinkwe retard) intake].
Topics: Adult; Aged; Angina, Unstable; Delayed-Action Preparations; Electrocardiography; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Time Factors; Treatment Outcome; Vasodilator Agents | 1999 |
[Influence of nitrates on red blood cell deformability and clinical parameters in patients with silent ischemia].
Topics: Adult; Aged; Coronary Vessels; Erythrocytes; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Treatment Outcome; Vasodilator Agents | 1997 |
Intermittent nitrate therapy for prior myocardial infaraction does not induce rebound angina nor reduce cardiac events.
Topics: Administration, Cutaneous; Administration, Oral; Aged; Angina Pectoris; Cardiovascular Agents; Coronary Vasospasm; Delayed-Action Preparations; Disease-Free Survival; Drug Administration Schedule; Drug Therapy, Combination; Drug Tolerance; Exercise Tolerance; Female; Follow-Up Studies; Heart Failure; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Nitroglycerin; Recurrence; Retrospective Studies; Treatment Outcome | 2000 |
Echocardiographical demonstration of a progressively expanding left ventricular aneurysm preceded by endomyocardial tearing.
Topics: Aged; Aneurysm, False; Antihypertensive Agents; Combined Modality Therapy; Coronary Disease; Disease Progression; Echocardiography; Endocardium; Female; Fibrin Tissue Adhesive; Heart Aneurysm; Heart Rupture; Heart Ventricles; Humans; Hypromellose Derivatives; Isosorbide Dinitrate; Methylcellulose; Myocardial Infarction; Nitroglycerin; Pericardial Effusion; Stroke Volume; Tissue Adhesives; Ventricular Remodeling | 2001 |
Fourth International Study of Infarct Survival: protocol for a large simple study of the effects of oral mononitrate, of oral captopril, and of intravenous magnesium. ISIS-4 collaborative group.
Topics: Administration, Oral; Captopril; Clinical Trials as Topic; Delayed-Action Preparations; Fibrinolytic Agents; Humans; Injections, Intravenous; Isosorbide Dinitrate; Magnesium; Multicenter Studies as Topic; Myocardial Infarction; Placebos; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Research Design; Risk Factors; Thrombolytic Therapy | 1991 |
[Comparison of the clinical and hemodynamic effects of nitroglycerin, isosorbide dinitrate and isosorbide-5-mononitrate in acute myocardial infarction].
Topics: Adult; Aged; Aged, 80 and over; Female; Humans; Infusions, Intravenous; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Nitroglycerin; Ventricular Function, Left | 1991 |
[Prognostic significance of disorders of regional left-ventricular contractility detected in the subacute period of myocardial infarction].
Topics: Adult; Cardiomyopathy, Dilated; Coronary Vessels; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Prognosis; Time Factors; Vasodilator Agents; Ventricular Function, Left | 1991 |
Pharmacokinetics of oral isosorbide-5-mononitrate in patients with ischemic heart failure.
Topics: Absorption; Adult; Aged; Central Venous Pressure; Chromatography, Gas; Coronary Disease; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction | 1991 |
Anti-ischemic and antianginal effects of 60 mg isosorbide-5-mononitrate in patients treated chronically after myocardial infarction.
Topics: Adult; Aged; Angina Pectoris; Delayed-Action Preparations; Drug Administration Schedule; Drug Tolerance; Exercise; Female; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction | 1990 |
The effects of oral isosorbide 5-mononitrate on mortality following acute myocardial infarction.
Topics: Humans; Isosorbide Dinitrate; Myocardial Infarction; Research Design; Survival Rate | 1990 |
[Use of isosorbide-5-mononitrate in acute myocardial infarction].
Topics: Adult; Aged; Blood Pressure; Female; Heart Rate; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction | 1989 |
A comparison of the haemodynamic effect of isosorbide-5-mononitrate and isosorbide dinitrate administered in intravenous injection to patients with acute myocardial infarction.
Topics: Aged; Female; Hemodynamics; Humans; Injections, Intravenous; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Stroke Volume; Vascular Resistance | 1989 |
[Hemodynamic effect of isosorbide-5-mononitrate in acute cardiac insufficiency secondary to myocardial infarct].
Topics: Acute Disease; Cardiac Output, Low; Drug Administration Schedule; Drug Evaluation; Hemodynamics; Humans; Isosorbide Dinitrate; Myocardial Infarction | 1989 |
Haemodynamic effects of intravenous isosorbide-5-mononitrate in acute and chronic left heart failure of ischaemic aetiology.
Topics: Aged; Blood Pressure; Cardiac Output; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Pulmonary Wedge Pressure | 1988 |
[Hemodynamic action of isosorbide-5-mononitrate during rapid venous administration in patients with acute myocardial infarct].
Topics: Adult; Aged; Cardiac Catheterization; Drug Evaluation; Female; Hemodynamics; Humans; Infusions, Intravenous; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Time Factors | 1988 |
Pituitary apoplexy following isosorbide administration.
Topics: Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Pituitary Apoplexy | 1987 |
Isosorbide 5-mononitrate in the treatment of left ventricular failure following acute myocardial infarction.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Blood Pressure; Cardiac Output; Heart Failure; Heart Rate; Humans; Injections, Intravenous; Isosorbide Dinitrate; Middle Aged; Myocardial Infarction | 1987 |
Isosorbide-5-mononitrate in the treatment of acute left ventricular failure following acute myocardial infarction.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Female; Heart Failure; Heart Rate; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Pulmonary Circulation; Time Factors | 1986 |